← FDA Drug Approvals (Drugs@FDA)

LYPQOZET

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2017-04-26

Drug application

FDA Application #

ANDA206084

Application type

Abbreviated New Drug Application (Generic)

Brand name

LYPQOZET

Generic name

Atorvastatin Calcium

Active ingredients

ATORVASTATIN CALCIUM; EZETIMIBE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PHARMOBEDIENT

First approval

2017-04-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown